Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D09YAS
|
|||
| Former ID |
DIB007875
|
|||
| Drug Name |
CYT-013-IL1bQb
|
|||
| Synonyms |
Immunodrug vaccines (IL-1 beta) (rheumatoid arthritis), Cytos
Click to Show/Hide
|
|||
| Drug Type |
Vaccine
|
|||
| Indication | Inflammation [ICD-11: 1A00-CA43.1] | Phase 1 | [1] | |
| Company |
Cytos Biotechnology AG
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT00924105) Safety, Tolerability and Pharmacodynamics of CYT013-IL1bQb in Patients With Type 2 Diabetes. U.S. National Institutes of Health. | |||
| REF 2 | URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 2623). | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.